GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Chaoju Eye Care Holdings Ltd (HKSE:02219) » Definitions » Peter Lynch Fair Value

Chaoju Eye Care Holdings (HKSE:02219) Peter Lynch Fair Value : HK$4.57 (As of May. 30, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Chaoju Eye Care Holdings Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Here, as of today, Chaoju Eye Care Holdings's PEG is 1. Chaoju Eye Care Holdings's 5-Year TTM EBITDA Growth Rate is 15.4. Chaoju Eye Care Holdings's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.30. Therefore, the Peter Lynch Fair Value for today is HK$4.57.

As of today (2025-05-30), Chaoju Eye Care Holdings's share price is HK$2.79. Chaoju Eye Care Holdings's Peter Lynch fair value is HK$4.57. Therefore, Chaoju Eye Care Holdings's Price to Peter Lynch Fair Value Ratio for today is 0.61.


The historical rank and industry rank for Chaoju Eye Care Holdings's Peter Lynch Fair Value or its related term are showing as below:

HKSE:02219' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.56   Med: 0.59   Max: 0.62
Current: 0.61


During the past 7 years, the highest Price to Peter Lynch Fair Value Ratio of Chaoju Eye Care Holdings was 0.62. The lowest was 0.56. And the median was 0.59.


HKSE:02219's Price-to-Peter-Lynch-Fair-Value is ranked better than
85.14% of 175 companies
in the Healthcare Providers & Services industry
Industry Median: 1.56 vs HKSE:02219: 0.61

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Chaoju Eye Care Holdings Peter Lynch Fair Value Historical Data

The historical data trend for Chaoju Eye Care Holdings's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chaoju Eye Care Holdings Peter Lynch Fair Value Chart

Chaoju Eye Care Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Peter Lynch Fair Value
Get a 7-Day Free Trial - - - 7.86 4.57

Chaoju Eye Care Holdings Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 7.86 - 4.57

Competitive Comparison of Chaoju Eye Care Holdings's Peter Lynch Fair Value

For the Medical Care Facilities subindustry, Chaoju Eye Care Holdings's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chaoju Eye Care Holdings's Price-to-Peter-Lynch-Fair-Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Chaoju Eye Care Holdings's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Chaoju Eye Care Holdings's Price-to-Peter-Lynch-Fair-Value falls into.


;
;

Chaoju Eye Care Holdings Peter Lynch Fair Value Calculation

Chaoju Eye Care Holdings's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* 15.4 *0.297
=4.57

For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Chaoju Eye Care Holdings's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.30.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


Chaoju Eye Care Holdings  (HKSE:02219) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 15.4 instead of 15 in this case.

Chaoju Eye Care Holdings's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=2.79/4.57
=0.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chaoju Eye Care Holdings Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of Chaoju Eye Care Holdings's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Chaoju Eye Care Holdings Business Description

Traded in Other Exchanges
N/A
Address
No. 14 Yard, West 3rd Ring South Road, Block A, Shouke Building, 24th Floor, East Zone, Fengtai District, Beijing, CHN
Chaoju Eye Care Holdings Ltd is a ophthalmic medical service group in North China engaged in engaged in the provision of in-patient services, out-patient services and sales of optical products. The company generate revenue from consumer ophthalmic services and basic ophthalmic services. The consumer ophthalmic services include treatments and prevention of various types of ophthalmic disorders, including refractive correction, myopia control and provision of optical products and services. The basic ophthalmic services include treatments of a wide range of common eye diseases, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases and pediatric eye diseases.
Executives
Zhang Junfeng 2103 Interests held jointly with another person
Zhang Xiaoli 2103 Interests held jointly with another person
Zhang Bozhou 2103 Interests held jointly with another person
Areo Holdings Limited 2201 Interest of corporation controlled by you
Li Gabriel 2201 Interest of corporation controlled by you
Lam Lai Ming 2201 Interest of corporation controlled by you
Orchid Asia Vii, L.p. 2201 Interest of corporation controlled by you
Orchid Asia Vii Gp, Limited 2201 Interest of corporation controlled by you
Orchid Asia V Group, Limited 2201 Interest of corporation controlled by you
Orchid Asia V Group Management, Limited 2201 Interest of corporation controlled by you
Oavii Holdings, L.p. 2201 Interest of corporation controlled by you
Orchid Asia Vii Global Investment Limited 2101 Beneficial owner
Wang Stephen Hui 2201 Interest of corporation controlled by you
Xia Men Chao Xi Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
Zhang Wenwen 2201 Interest of corporation controlled by you

Chaoju Eye Care Holdings Headlines

No Headlines